NCT03899155From ClinicalTrials.govRecruiting

Pan Tumor Rollover Study

Pan-Tumor Study for Long-term Treatment of Cancer Patients Who Have Participated in BMS Sponsored Trials Investigating Nivolumab and Other Cancer Therapies

Cancer

At a glance

Phase: Phase 2
Study type: Interventional
Sponsor: Bristol-Myers Squibb
Enrolment target: 1,500
Started: 9 August 2019
Main results due: 25 August 2029
Study sites: 399
Registry updated: 23 September 2026

Can you take part?

Aged 18 years and over.
Open to any sex.
You need the condition being studied — healthy volunteers are not accepted.

These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.

Read the full eligibility criteria

Inclusion Criteria

* Signed Written Informed Consent.
* Eligible to receive continued study treatment per the Parent Study, including treatment beyond progression per investigator assessment in the Parent Study.
* On treatment hold in the Parent Study following long-lasting response or are eligible for treatment rechallenge as defined in the Parent Study.
* WOCBP and male participants who are sexually active must agree to follow instructions for method(s) of contraception as described below and included in the ICF.

Exclusion Criteria

* Participant is not eligible for study treatment per the Parent Study eligibility criteria.
* Participants not receiving clinical benefit as assessed by the Investigator.
* Any clinical adverse event (AE), laboratory abnormality, or intercurrent illness which, in the opinion of the Investigator, indicates that participation in the study is not in the best interest of the participant.
* Other protocol-defined Inclusion/Exclusion Criteria apply

What this study is about

In the sponsor’s own words, from the registry.

Main Objective of this study is to examine long-term safety of nivolumab monotherapy including combinations and other cancer therapies in various tumor types.

Study sites(399)

Local Institution - 0220
Huntsville, Alabama, United States
Completed
University of Arizona College of Medicine
Tucson, Arizona, United States
Withdrawn
Innovative Clinical Research Institute
Lynwood, California, United States
Withdrawn
Local Institution
San Francisco, California, United States
Withdrawn
Local Institution - 0099
San Francisco, California, United States
Completed
Local Institution - 0233
Aurora, Colorado, United States
Completed
Local Institution - 0095
New Haven, Connecticut, United States
Withdrawn
Local Institution - 0088
Washington D.C., District of Columbia, United States
Completed
Florida Cancer Affiliates
Ocala, Florida, United States
Withdrawn
Local Institution
Orlando, Florida, United States
Withdrawn
Local Institution - 0024
Tampa, Florida, United States
Completed
Local Institution - 0105
Chicago, Illinois, United States
Completed
Local Institution
Maywood, Illinois, United States
Withdrawn
Local Institution - 0279
Park Ridge, Illinois, United States
Completed
Local Institution - 0186
Westwood, Kansas, United States
Completed
Local Institution - 0165
Wichita, Kansas, United States
Completed
University of Louisville-James Graham Brown Cancer Center
Louisville, Kentucky, United States
Recruiting
Local Institution - 0092
Baltimore, Maryland, United States
Completed
Local Institution - 0039
Boston, Massachusetts, United States
Completed
Dana_Farber Cancer Institute (DFCI)
Boston, Massachusetts, United States
Recruiting
Local Institution - 0081
Boston, Massachusetts, United States
Withdrawn
Local Institution - 0143
Ann Arbor, Michigan, United States
Completed
Local Institution - 0100
Minneapolis, Minnesota, United States
Completed
Local Institution
St Louis, Missouri, United States
Withdrawn
Local Institution - 0205
Omaha, Nebraska, United States
Completed
Local Institution - 0014
Lebanon, New Hampshire, United States
Completed
Local Institution
Albuquerque, New Mexico, United States
Withdrawn
Local Institution - 0128
Buffalo, New York, United States
Completed
NYU Langone Hematology Oncology Associates-Mineola
Mineola, New York, United States
Recruiting
Local Institution
New York, New York, United States
Withdrawn
Local Institution - 0185
New York, New York, United States
Completed
Local Institution - 0202
New York, New York, United States
Withdrawn
Local Institution
New York, New York, United States
Withdrawn
Local Institution - 0204
Charlotte, North Carolina, United States
Completed
Local Institution - 0016
Durham, North Carolina, United States
Completed
Oncology Hematology Care
Cincinnati, Ohio, United States
Recruiting
Local Institution - 0408
Cincinnati, Ohio, United States
Completed
Local Institution
Cleveland, Ohio, United States
Withdrawn
The Ohio University
Columbus, Ohio, United States
Recruiting
Local Institution - 0246
Tulsa, Oklahoma, United States
Withdrawn
Local Institution - 0037
Allentown, Pennsylvania, United States
Completed
Local Institution - 0054
Easton, Pennsylvania, United States
Completed
Lancaster General Health
Lancaster, Pennsylvania, United States
Recruiting
Allegheny Valley Hospital
Natrona Heights, Pennsylvania, United States
Withdrawn
Local Institution
Philadelphia, Pennsylvania, United States
Withdrawn
Local Institution - 0162
Philadelphia, Pennsylvania, United States
Withdrawn
Local Institution - 0110
Pittsburgh, Pennsylvania, United States
Completed
Local Institution - 0228
Charleston, South Carolina, United States
Completed
Local Institution
Greenville, South Carolina, United States
Withdrawn
Local Institution
Chattanooga, Tennessee, United States
Withdrawn
Tennesse Oncology
Nashville, Tennessee, United States
Recruiting
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Withdrawn
Local Institution
Dallas, Texas, United States
Withdrawn
Local Institution - 0364
Houston, Texas, United States
Withdrawn
Local Institution - 0055
Salt Lake City, Utah, United States
Completed
Local Institution
Charlottesville, Virginia, United States
Withdrawn
Public Hospital of King County District 1 Valley Medical Center
Renton, Washington, United States
Withdrawn
Local Institution - 0065
Madison, Wisconsin, United States
Completed
Local Institution - 0124
Madison, Wisconsin, United States
Withdrawn
Local Institution - 0199
Berazategui, Buenos Aires, Argentina
Completed

Showing 60 of 399 sites — filter to narrow it down. 108 of the 399 sites on this study are recruiting right now — a site can stop enrolling while the study as a whole is still open.

Source: ClinicalTrials.gov record NCT03899155. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.

Not the right study?

Answer three questions and see the studies recruiting near you, in plain language.

Find a study for me